Cullinan Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGEM and other ETFs, options, and stocks.

About CGEM

Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. 

CEO
Nadim Ahmed
CEONadim Ahmed
Employees
111
Employees111
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2016
Founded2016
Employees
111
Employees111

CGEM Key Statistics

Market cap
462.26M
Market cap462.26M
Price-Earnings ratio
-2.23
Price-Earnings ratio-2.23
Dividend yield
—
Dividend yield—
Average volume
1.85M
Average volume1.85M
High today
$8.02
High today$8.02
Low today
$7.38
Low today$7.38
Open price
$7.60
Open price$7.60
Volume
1.87M
Volume1.87M
52 Week high
$17.98
52 Week high$17.98
52 Week low
$5.68
52 Week low$5.68

Analyst ratings

100%

of 11 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own CGEM. This list is generated using Robinhood data, and it’s not a recommendation.
Riot Platforms
Moderna
Viking Therapeutics
Lucid Group
Iovance Biotherapeutics
Plug Power
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.